Fortrea (FTRE) Competitors $19.15 +0.47 (+2.52%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FTRE vs. HIMS, SHC, GH, OPCH, BTSG, VCYT, SGRY, LFST, PACS, and CONShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include Hims & Hers Health (HIMS), Sotera Health (SHC), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), PACS Group (PACS), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Fortrea vs. Hims & Hers Health Sotera Health Guardant Health Option Care Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group PACS Group Concentra Group Holdings Parent Hims & Hers Health (NYSE:HIMS) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, community ranking, media sentiment, risk, profitability, earnings and institutional ownership. Which has more risk & volatility, HIMS or FTRE? Hims & Hers Health has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Does the media refer more to HIMS or FTRE? In the previous week, Hims & Hers Health had 31 more articles in the media than Fortrea. MarketBeat recorded 33 mentions for Hims & Hers Health and 2 mentions for Fortrea. Fortrea's average media sentiment score of 0.70 beat Hims & Hers Health's score of 0.26 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 10 Very Positive mention(s) 7 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate HIMS or FTRE? Hims & Hers Health currently has a consensus target price of $20.71, suggesting a potential downside of 4.98%. Fortrea has a consensus target price of $24.50, suggesting a potential upside of 27.94%. Given Fortrea's higher possible upside, analysts clearly believe Fortrea is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38Fortrea 1 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.25 Which has higher earnings and valuation, HIMS or FTRE? Fortrea has higher revenue and earnings than Hims & Hers Health. Fortrea is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$872M5.46-$23.55M$0.4449.55Fortrea$3.11B0.55-$3.40M-$3.42-5.60 Does the MarketBeat Community believe in HIMS or FTRE? Hims & Hers Health received 26 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 37.37% of users gave Hims & Hers Health an outperform vote while only 27.50% of users gave Fortrea an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes3737.37% Underperform Votes6262.63% FortreaOutperform Votes1127.50% Underperform Votes2972.50% Is HIMS or FTRE more profitable? Hims & Hers Health has a net margin of 8.19% compared to Fortrea's net margin of -10.99%. Hims & Hers Health's return on equity of 10.97% beat Fortrea's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Fortrea -10.99%2.00%0.80% Do insiders and institutionals hold more shares of HIMS or FTRE? 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 0.1% of Fortrea shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryHims & Hers Health beats Fortrea on 14 of the 19 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68B$3.06B$5.06B$8.89BDividend YieldN/A11.18%4.97%4.06%P/E Ratio-5.609.3789.0213.30Price / Sales0.55215.941,207.2881.01Price / Cash7.51406.7839.1736.03Price / Book1.144.026.085.74Net Income-$3.40M-$32.86M$119.07M$225.93M7 Day Performance-5.20%0.56%-1.84%-1.32%1 Month Performance1.16%-0.22%-3.65%0.60%1 Year Performance-41.33%26.01%31.62%26.23% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea3.5768 of 5 stars$19.15+2.5%$24.50+27.9%-40.7%$1.68B$3.11B-5.6018,000HIMSHims & Hers Health3.5685 of 5 stars$21.80-7.4%$20.71-5.0%+181.8%$5.14B$872M49.551,046Analyst ForecastInsider TradeSHCSotera Health3.662 of 5 stars$13.21-2.9%$16.50+24.9%-5.2%$3.85B$1.05B52.843,000High Trading VolumeGHGuardant Health4.2853 of 5 stars$30.68flat$40.60+32.3%+28.4%$3.79B$563.95M0.001,779OPCHOption Care Health4.9784 of 5 stars$21.88+0.3%$30.83+40.9%-26.3%$3.71B$4.30B18.397,802Positive NewsBTSGBrightSpring Health Services2.9593 of 5 stars$18.79+0.8%$16.79-10.6%N/A$3.25B$8.83B0.0035,000Positive NewsVCYTVeracyte4.1264 of 5 stars$39.20+0.1%$41.25+5.2%+50.5%$3.03B$361.05M-261.33790Analyst ForecastSGRYSurgery Partners3.0975 of 5 stars$22.51-1.1%$38.71+72.0%-29.9%$2.89B$2.74B-46.9013,500Analyst ForecastLFSTLifeStance Health Group1.7828 of 5 stars$7.22-0.3%$8.50+17.7%+16.5%$2.77B$1.06B0.009,325PACSPACS Group4.0685 of 5 stars$17.25+0.9%$39.88+131.2%N/A$2.61B$3.11B0.0032,433Analyst ForecastCONConcentra Group Holdings ParentN/A$21.27+4.9%$28.50+34.0%N/A$2.58B$1.84B0.0011,000Gap UpHigh Trading Volume Related Companies and Tools Related Companies HIMS Competitors SHC Competitors GH Competitors OPCH Competitors BTSG Competitors VCYT Competitors SGRY Competitors LFST Competitors PACS Competitors CON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FTRE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
